晚期卵巢癌伴恶性腹水患者的临终关怀与护理

秦艳玲

秦艳玲. 晚期卵巢癌伴恶性腹水患者的临终关怀与护理[J]. 实用临床医药杂志, 2014, (8): 20-22,28. DOI: 10.7619/jcmp.201408007
引用本文: 秦艳玲. 晚期卵巢癌伴恶性腹水患者的临终关怀与护理[J]. 实用临床医药杂志, 2014, (8): 20-22,28. DOI: 10.7619/jcmp.201408007
QIN Yanling. Hospice and nursing of advanced ovarian cancer patients combined with malignant ascites[J]. Journal of Clinical Medicine in Practice, 2014, (8): 20-22,28. DOI: 10.7619/jcmp.201408007
Citation: QIN Yanling. Hospice and nursing of advanced ovarian cancer patients combined with malignant ascites[J]. Journal of Clinical Medicine in Practice, 2014, (8): 20-22,28. DOI: 10.7619/jcmp.201408007

晚期卵巢癌伴恶性腹水患者的临终关怀与护理

详细信息
  • 中图分类号: R473.73

Hospice and nursing of advanced ovarian cancer patients combined with malignant ascites

  • 摘要: 目的:观察临终关怀和护理对晚期卵巢癌伴恶性腹水患者的影响。方法本研究共纳入晚期卵巢癌伴恶性腹水患者248例,均经腹腔穿刺灌注化疗和射频热疗治疗,并给予临终关怀和护理。采用生活质量评定表(QLQ-C 30)评定患者治疗前后的社会功能、情绪功能、角色功能,同时采用焦虑自评量表(SAS)和抑郁自评量表(SDS)评价治疗前后患者的心理状况。结果临终关怀和护理后患者社会功能、情绪功能和角色功能评分均高于护理前,SAS 和 SDS 评分均优于护理前(P<0.05)。结论临终关怀和护理能提高晚期卵巢癌伴恶性腹水患者的生活质量,减轻患者的焦虑、抑郁情绪,值得临床推广。
    Abstract: Objective To observe the impact of hospice and nursing on advanced ovarian cancer patients combined with malignant ascites.Methods 248 patients with advanced ovarian cancer combined with malignant ascites,who were treated by abdominal puncture infusion chemotherapy and radiofrequency hyperthermia therapy,were given hospice and nursing.Social function,emotional function and role function were evaluated by Quality of Life Assessment form (QLQ-C 30)before and after treatment and the psychological status of patients was evaluated be-fore and after treatment by Self-rating Anxiety Scale (SAS)and Self-rating Depression Scale (SDS).Results After hospice and nursing,socity function,emotional function and role function scores of patients were higher than that before the treatment.SAS and SDS scores were better than that before treatment(P <0.05).Conclusion Hospice and nursing can improve quality of life of patients with advanced ovarian cancer combined with malignant ascites and reduce anxiety and de-pression,so it is worthy of promotion.
  • 期刊类型引用(8)

    1. 杨增芯,李伟章,翁玉龙,陈兵,陆鑫. 沙库巴曲缬沙坦对COPD合并心力衰竭患者心功能的影响. 临床合理用药. 2025(01): 1-3+7 . 百度学术
    2. 刘媛,王澎,聂静. 血清BNP、CRP、PCT水平对慢阻肺急性加重期患者并发心力衰竭的预测价值. 航空航天医学杂志. 2024(03): 270-273 . 百度学术
    3. 周蓓,邱饶元. 慢性阻塞性肺疾病急性发作合并心力衰竭患者使用那屈肝素的临床效果研究. 现代诊断与治疗. 2024(13): 1932-1934+1966 . 百度学术
    4. 冯双喜,袁天舒,林惠霞,伍利群. 不同标本类型中超敏C反应蛋白检验结果在脑瘫儿童感染性疾病治疗中的一致性分析. 中国医药指南. 2024(33): 41-43 . 百度学术
    5. 康林,祝莹,高芸,黄瑾,李润洁. 血清降钙素、脑钠肽、心肌肌钙蛋白Ⅰ与老年肺炎病情严重程度的关系. 实用临床医药杂志. 2023(17): 93-96 . 本站查看
    6. 缪雄,吉鹏,钱晶,陆洋. 低分子肝素联合卡维地络对COPD合并心力衰竭患者心肺功能和相关指标的影响. 中南医学科学杂志. 2022(05): 732-735 . 百度学术
    7. 汪晶,彭博,王海存,崔晶,谭立业. 超滤联合注射用益气复脉治疗难治性心力衰竭的效果. 中国当代医药. 2022(28): 92-95 . 百度学术
    8. 王小荣. 伊伐布雷定在COPD合并心力衰竭患者临床应用分析. 中外医疗. 2021(18): 94-97 . 百度学术

    其他类型引用(1)

计量
  • 文章访问数:  186
  • HTML全文浏览量:  37
  • PDF下载量:  1
  • 被引次数: 9
出版历程
  • 发布日期:  2014-07-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭